Legal Representation
Attorney
Bingham B. Leverich, Esq.
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 27, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 27, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 28, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 27, 2010 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 26, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 26, 2010 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 17, 2009 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 10, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 10, 2009 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 3, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 3, 2009 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 15, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 15, 2009 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 4, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 4, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 4, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 27, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 13, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 25, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 25, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 12, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 12, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 3, 2007 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of diabetes and cardiovascular diseases including hyperlipidemia, atherosclerosis, myocardial infarction, angina pectoris and stroke
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005